Get all your news in one place.
100's of premium titles.
One app.
Start reading
Dynamite News
Dynamite News
National
DN Bureau

Researchers find dupilumab reduces disease in COPD patients with type 2 inflammation

Representational Image

Washington: Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.